Treatment of Carbon Monoxide (CO) Poisoning
1. Immediate Management (Cornerstones)
A. Remove source & supportive care
- Immediate removal from CO exposure
- Assess ABCs (airway, breathing, circulation)
- Continuous cardiac monitoring and pulse oximetry (note: pulse oximetry may appear falsely normal)
B. 100% Oxygen Therapy (First-line for all patients)
- Non-rebreather mask at 10–15 L/min (or ventilator with 100% FiO₂ if intubated)
- Reduces CO half-life:
- Room air: ~4–6 hours
- 100% O₂: ~60–90 minutes
- Hyperbaric O₂: ~20–30 minutes
Duration
- Continue until patient is asymptomatic and carboxyhemoglobin (COHb) <5%
- Smokers may have baseline COHb up to 5–10%
2. Hyperbaric Oxygen Therapy (HBOT)
Mechanism
- Accelerates CO dissociation from hemoglobin
- Improves tissue oxygen delivery
- Reduces delayed neurologic sequelae (DNS) by limiting oxidative injury
Common Indications (any of the following):
- COHb ≥25% (≥20% often used in pregnancy)
- Pregnancy with COHb ≥15–20% or fetal distress
- Loss of consciousness, syncope, coma
- Severe neurologic symptoms (confusion, focal deficits)
- Cardiac ischemia, arrhythmias, chest pain
- Severe metabolic acidosis (pH <7.1)
Pharmacist note:
- Evidence is mixed, but HBOT is widely recommended for high-risk patients due to potential benefit in preventing DNS.
3. Symptom-Directed & Supportive Therapy
| Issue | Management |
|---|---|
| Seizures | Benzodiazepines (e.g., lorazepam) |
| Hypotension | IV fluids ± vasopressors |
| Arrhythmias / ischemia | ACLS protocols |
| Rhabdomyolysis | Aggressive IV fluids, monitor CK |
| Metabolic acidosis | Oxygen + supportive care (bicarbonate rarely needed) |
4. Monitoring & Investigations
- COHb level (co-oximetry; ABG preferred)
- ABG/VBG for acid–base status
- ECG & troponin (especially adults ≥35 yrs or cardiac symptoms)
- Lactate (marker of hypoxia)
- Neurologic assessment (baseline and follow-up)
5. Special Populations
Pregnancy
- Lower threshold for HBOT
- Fetal hemoglobin binds CO more avidly → prolonged fetal hypoxia
Children & elderly
- Higher risk of neurologic sequelae
- Consider HBOT at lower COHb thresholds if symptomatic
6. Delayed Neurologic Sequelae (DNS)
- Can occur days to weeks after exposure
- Symptoms: memory loss, gait disturbance, personality changes, parkinsonism
- Patient counseling & follow-up are essential
7. Role of the Clinical Pharmacist
- Ensure timely high-flow O₂ initiation
- Identify HBOT eligibility
- Manage seizure prophylaxis/treatment
- Review drug interactions and cardiotoxic meds
- Support ICU protocols and transitions of care
- Provide discharge counseling (CO detector use, follow-up)
One-Line Clinical Summary
Carbon monoxide poisoning is treated with immediate high-flow 100% oxygen to rapidly displace CO from hemoglobin, with hyperbaric oxygen reserved for severe poisoning or high-risk patients to reduce neurologic and cardiac complications.

